IRCT20230526058300N1招募中2 期
Investigation of the oral (propranolol) and topical beta-blocker (Timolol eye drop) drugs in preventing the exacerbation of retinopathy of prematurity of stage 2 and above in premature neonates
Karaj University of Medical Sciences0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 189 days 至 224 days（—）
- 性别
- All
入选标准
- •Gestational age less than 34 weeks
- •Premature infants between 26 weeks and 34 weeks, who underwent ophthalmic examination from the fourth to the twelfth week of birth and it was determined that they have stage 2 ROP and above.
排除标准
- •Infants with congenital or acquired cardiac anomalies
- •ROP stage 1
- •Unstable hemodynamic
研究者
相似试验
已完成
4 期
Treatment of Superficial Infantile Haemangiomas with Timolol and PropranololCTRI/2021/05/033307Varun Gupta40
已完成
2 期
The comparison between effect of orally propranolol lorazpam and propranolol-lorazpam in reduction of preoperative anexietyeurotic, stress-related and somatoform disorders.Phobic anxiety disorder, unspecifiedIRCT201106146256N2vice-chancellor for research of Qazvin universityof medical science75
招募中
3 期
Investigating the efficacy of oral propranolol in prevention of severe Retinopathy of PrematurityRetinopathy of prematurityIRCT20101018004961N12Kermanshah University of Medical Sciences50
已完成
2 期
Oral propranolol and retinopathy of prematurityRetinopathy of prematurityIRCT20100512003915N21Tabriz University of Medical Sciences72
招募中
1 期
Evaluating the effect of oral Propranolol in preventing the progression of retinopathy of prematurityretinopathy of prematurity.Retinopathy of prematurity, unspecified, bilateralH35.103IRCT20230717058817N1Ardabil University of Medical Sciences66